The Trump administration is seeking to become more self sufficient in the production of semiconductors rather than being reliance on semiconductors made overseas, hoping to spur domestic manufacturing and reshape global supply chains (as reported in WSJ) This comes as the US announced Friday that 100% tariffs will be levied on pharmaceutical products, seemingly targeting China and India. The semi-conductor news saw the likes of TSMC down -1.50% and Samsung -4.30% whilst Pharma companies in India. Market leaders like Dr. Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma and Gland Pharma derive between 30-50% of their overall revenues from the American market with some down 3-4% this week.
Find more articles and bullets on these widgets:
Bund futures continue to trade above their recent lows. A bear threat remains present. The contract recently breached 128.84, the Jul 25 low and a bear trigger. Note that the 129.00 handle represents the base of a broad range. A clear range breakout would strengthen a bearish theme. This would open 128.40 initially, the Apr 9 low. Strength above the 50-day EMA of 129.78, is required to signal a reversal.
The recent uptrend for China's stocks continued today with major bourses delivering gains as markets turn their attention to Nvidia's earnings and the US inflation report to come. Tech shares in the region remain strong with key AI companies in focus.
Oil prices are little changed in today’s APAC session following a sharp sell off on Tuesday. WTI is around $63.25/bbl after falling to $63.15 and reaching $63.46 early in trading. Brent is 0.1% higher at $67.26/bbl off the intraday low of $67.13. The USD index is 0.2% higher.